Revista Biomédica Revisada Por Pares
Para Descargar PDF debe Abrir sesión.
Palabras clave: Morvan's syndrome, intravenous immunoglobulins, thymic carcinoma, thymoma
Morvan's syndrome is a rare autoimmune channelopathy. A case of Morvan's syndrome is presented as a paraneoplastic syndrome associated to the recurrence of a well-differentiated thymic carcinoma, which showed a good clinical response to treatment with intravenous immunoglobulin.
Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.
Morvan's syndrome is a rare autoimmune channelopathy. A case of Morvan's syndrome is presented as a paraneoplastic syndrome associated to the recurrence of a well-differentiated thymic carcinoma, which showed a good clinical response to treatment with intravenous immunoglobulin.
Authors:
Gabriel Horta Baas[1]
Citación: Horta Baas G. Intravenous immunoglobulin therapy in Morvan syndrome secondary to recurrent thymic carcinoma. Medwave 2015 Nov;15(10):e6323 doi: 10.5867/medwave.2015.10.6323
Fecha de envío: 4/5/2015
Fecha de aceptación: 7/11/2015
Fecha de publicación: 25/11/2015
Origen: not requested
Tipo de revisión: reviewed by four external peer reviewers, double-blind
Nos complace que usted tenga interés en comentar uno de nuestros artículos. Su comentario será publicado inmediatamente. No obstante, Medwave se reserva el derecho a eliminarlo posteriormente si la dirección editorial considera que su comentario es: ofensivo en algún sentido, irrelevante, trivial, contiene errores de lenguaje, contiene arengas políticas, obedece a fines comerciales, contiene datos de alguna persona en particular, o sugiere cambios en el manejo de pacientes que no hayan sido publicados previamente en alguna revista con revisión por pares.
Aún no hay comentarios en este artículo.
Para comentar debe iniciar sesión
Medwave publica las vistas HTML y descargas PDF por artículo, junto con otras métricas de redes sociales.
Ruggieri VL, Arberas CL. [Neuromuscular hereditary channelopathies: non-dystrophic myotonias, paramyotonias and periodic paralysis]. Rev Neurol. 2002 Jan 16-31;34(2):150-6. | PubMed |Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012 Aug;72(2):241-55. | CrossRef | PubMed |Lee W, Day TJ, Williams DR. Clinical, laboratory and electrophysiological features of Morvan's fibrillary chorea. J Clin Neurosci. 2013 Sep;20(9):1246-9. | CrossRef | PubMed |Panagariya A, Kumar H, Mathew V, Sharma B. Neuromyotonia: clinical profile of twenty cases from northwest India. Neurol India. 2006 Dec;54(4):382-6. | PubMed |Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001 Dec;124(Pt 12):2417-26. | PubMed |Gállego Pérez-Larraya J, Dalmau J. [Classic paraneoplastic syndromes: diagnostic and treatment approach]. Neurologia. 2008 Sep;23(7):441-8. | PubMed |Montojo MT, Petit-Pedrol M, Graus F, Dalmau J. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex. Neurologia. 2015 Jun;30(5):295-301. | CrossRef | PubMed |Merchut MP. Management of voltage-gated potassium channel antibody disorders. Neurol Clin. 2010 Nov;28(4):941-59. | CrossRef | PubMed |Abou-Zeid E, Boursoulian LJ, Metzer WS, Gundogdu B. Morvan syndrome: a case report and review of the literature. J Clin Neuromuscul Dis. 2012 Jun;13(4):214-27. | CrossRef | PubMed |Cottrell DA, Blackmore KJ, Fawcett PR, Birchall D, Vincent A, Barnard S,et al. Sub-acute presentation of Morvan's syndrome after thymectomy. J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1504-5. | PubMed |Bataller L, Dalmau J. Paraneoplastic neurologic syndromes. Neurol Clin N Am. 21:221-227. | CrossRef |van den Berg JS, van Engelen BG, Boerman RH, de Baets MH. Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin. J Neurol. 1999 Jul;246(7):623-5. | PubMed |Graves D, Vernino S. Immunotherapies in neurologic disorders. Med Clin North Am. 2012 May;96(3):497-523, x. | CrossRef | PubMed |Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2006 Jul;13(7):691-9. | PubMed |Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y. Evidence for the use of intravenous immunoglobulins--a review of the literature. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):201-69. | CrossRef | PubMed |Bayry J, Negi VS, Kaveri SV. Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol. 2011 Jun;7(6):349-59. | CrossRef | PubMed |Ho WK, Wilson JD. Hypothermia, hyperhidrosis, myokymia and increased urinary excretion of catecholamines associated with a thymoma. Med J Aust. 1993 Jun 7;158(11):787-8.
| PubMed |Alessi G, De Reuck J, De Bleecker J, Vancayzeele S. Successful immunoglobulin treatment in a patient with neuromyotonia. Clin Neurol Neurosurg. 2000 Sep;102(3):173-5. | PubMed |
Estudios originales